Immune System News and Research

RSS

Innovative smallpox vaccine research study to be conducted at Case Medical Center

University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease.

3 Jun 2007

Fat protein cuts blood vessel inflammation, may help heart

A natural substance secreted by fat cells can protect blood vessels from the damaging effects of inflammation, one of the factors that contribute to heart disease.

3 Jun 2007

Brain inflammation may actually be a friend for Alzheimer's patients

Inflammation in the brain may not be so bad after all when it comes to Alzheimer's disease.

3 Jun 2007

Research points to a broadly-protective HIV vaccine

New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus.

1 Jun 2007

New animal model for Lassa fever

Scientists at the Southwest Foundation for Biomedical Research have developed a new tool in the battle against a potential biological weapon, Lassa fever, which kills several thousand people each year and leaves thousands more with disabilities such as deafness and liver damage.

1 Jun 2007

New tests for leishmaniasis and leprosy

The Seattle-based Infectious Disease Research Institute (IDRI) and Chembio Diagnostics, Inc. have entered into two research and development agreements for the development of rapid diagnostic tests for Leishmaniasis and Leprosy, two "neglected diseases" targeted by IDRI.

1 Jun 2007

Cytomegalovirus exacerbates atherosclerosis through an autoimmune mechanism

A new study conducted by researchers from the University of Verona and the Institute G. Gaslini in Genova, Italy, confirms the pivotal role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis.

1 Jun 2007

Researchers find cure for dogs with sudden acquired retinal degeneration syndrome

If two dogs are any indication, Iowa State University veterinary researchers may have found a cure for a previously incurable disease that causes dogs to go blind suddenly.

1 Jun 2007

International studies show high efficacy for Gardasil

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer, strains 16 and 18.

1 Jun 2007

Study suggests potential for a broadly-protective HIV vaccine

30 May 2007

New class of compounds shows promise for cancer treatment

A new class of compounds developed by two University of Kentucky researchers shows promise as a nontoxic treatment of some cancers previously treated with toxic chemotherapy, the researchers report.

30 May 2007

Human antibodies protect mice from H5N1 avian influenza

An international team of scientists, including researchers from the National Institute of Allergy and Infectious Diseases (NIAID), report using antibodies derived from immune cells from recent human survivors of H5N1 avian influenza to successfully treat H5N1-infected mice as well as protect them from an otherwise lethal dose of the virus.

30 May 2007

HIV and malaria combine to adversely affect pregnant women and their infants

University of Toronto researchers have uncovered the basis by which pregnant women protect themselves against malaria and have also discovered how the HIV virus works to counteract this defence.

30 May 2007

Key role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis

30 May 2007

Blood of bird flu survivors promises new treatment for the deadly virus

Scientists are optimistic that blood donated by four survivors of bird flu will offer some clues as to why some people appear to have protection against the deadly H5N1 virus.

29 May 2007

Significant breakthrough in the search for an effective malaria vaccine

One person dies of it every 30 seconds, it rivals HIV and tuberculosis as the world's most deadly infection and the vast majority of its victims are under five years old.

28 May 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007